Item 2.02. Results of Operations and Financial Condition.
VIA Pharmaceuticals, Inc. (the "Company") plans to conduct a presentation on November 12, 2008 regarding its business, which contains information regarding the Company's financial results for the quarter ended September 30, 2008. See Item 7.01.
Item 7.01. Regulation FD Disclosure.
From time to time, the Company plans to conduct presentations to third parties regarding its business, including a presentation on November 12, 2008. The current slides for the Company's corporate presentation are attached to this report as Exhibit 99.1 and the information set forth therein is incorporated by reference herein.
The information contained in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished to the Securities and Exchange Commission and shall not be deemed to be "filed" for the purposes of Section 18 of the Exchange Act or otherwise subject to liabilities of that Section, nor shall it be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act. Item 9.01. Financial Statements and Exhibits.
(d) Exhibits

Exhibit No. Description
99.1 Slide Presentation

---